LSE - Delayed Quote GBp
Physiomics Plc (PYC.L)
At close: October 18 at 3:55 PM GMT+1
Research Analysis
Revenue vs. Earnings
Revenue 94.28k
Earnings -201.68k
Analyst Price Targets
No Analyst Price Targets available for this ticker
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.45 | -0.34 |
| Low Estimate | 0 | 0 | -0.45 | -0.34 |
| High Estimate | 0 | 0 | -0.45 | -0.34 |
| Year Ago EPS | -- | -- | -0.49 | -0.45 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 600k | 720k |
| Low Estimate | -- | -- | 600k | 720k |
| High Estimate | -- | -- | 600k | 720k |
| Year Ago Sales | -- | -- | 597k | 600k |
| Sales Growth (year/est) | -- | -- | 0.50% | 20.00% |
Earnings History
| CURRENCY IN USD | |
|---|---|
| EPS Est. | -- |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.45 | -0.34 |
| 7 Days Ago | 0 | 0 | -0.45 | -0.34 |
| 30 Days Ago | 0 | 0 | -0.45 | 0 |
| 60 Days Ago | 0 | 0 | -0.25 | 0 |
| 90 Days Ago | 0 | 0 | -0.25 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PYC.L | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.70% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | 8.20% | -- | -- | 2.50% |
| Next Year | 24.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
BST.MC Biotechnology Assets, S.A.
0.3010
+1.86%
CIZ.L Cizzle Biotechnology Holdings Plc
1.9500
0.00%
SAR.L Sareum Holdings plc
27.00
-3.57%
HEMO.L Hemogenyx Pharmaceuticals Plc
1.4110
+26.66%
NEU.AX Neuren Pharmaceuticals Limited
13.13
+0.15%
NMRA Neumora Therapeutics, Inc.
16.49
-2.77%
PDSB PDS Biotechnology Corporation
3.2500
+4.84%
ITRM Iterum Therapeutics plc
1.1700
+7.34%